Skip to main content

Home/ Cerebral Palsy/ Group items tagged reflux in infants

Rss Feed Group items tagged

Lee Vander Loop

Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux... - 0 views

  •  
    Study conducted and completed to evaluate the efficacy, acceptability, and safety of Axid Oral Solution versus placebo in the treatment of gastroesophageal reflux disease (GERD) in infants age 30 days up to 1 year.
Lee Vander Loop

Gastroesophageal Reflux in Infants - 0 views

  •  
    Gastroesophageal Reflux in Infants - National Digestive Diseases Information Clearninghouse - A to Z list, Facts and answers
Lee Vander Loop

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Ga... - 0 views

  •  
    Study to assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD)
Lee Vander Loop

A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and... - 0 views

  •  
    Study is to evaluate the pharmacokinetics (blood levels), pharmacodynamics (how the drug acts on the body), and the safety of rabeprazole sodium for the treatment of gastroesophageal reflux disease (GERD) in new borns and pre-term infants (less than 44 weeks of age).
Lee Vander Loop

Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux... - 0 views

  •  
    Study is to evaluate the efficacy, acceptability, and safety of Axid Oral Solution versus placebo in the treatment of gastroesophageal reflux disease (GERD) in infants age 30 days up to 1 year.
Lee Vander Loop

Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants - 0 views

  •  
    Study Question: In premature infants with apnea and/or bradycardia attributed to gastroesophageal reflux disease (GERD), does treatment with medications (acid blockers and motility agents), compared to placebo, reduce the frequency of apnea and bradycardia?"
Lee Vander Loop

To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Ero... - 0 views

  •  
    Purpose of this study is to assess the effectiveness and safety of rabeprazole sodium, an inhibitor of gastric acid secretion of the protein pump inhibitor (PPI) class, compared with placebo in the treatment of gastrointestinal esophageal reflux disease (GERD) in infants 1 to 11 months of age.
Lee Vander Loop

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than... - 0 views

  •  
    Purpose of this completed study is to provide additional information on safety and tolerability after multiple doses of pantoprazole in infants
Lee Vander Loop

The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infant... - 0 views

  •  
    Ongoing study sponsored by the University of Texas Health Science Center, Houston to evaluate the efficacy of fundoplication in premature infants with GERD and BPD.
Lee Vander Loop

Feed thickener for newborn infants with gastro-oesophageal reflux - 0 views

  •  
    "This is an update of the review "Feed thickener for newborn infants with gastro-oesophageal reflux" published in The Cochrane Library, Issue 3, 2002 (Huang 2002)."
Lee Vander Loop

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than... - 0 views

  •  
    The purpose of this study is to provide additional information on safety and tolerability after multiple does of pantoprazole in infants
Lee Vander Loop

Feeding problems in infants with gastro-oesophagea... [J Paediatr Child Health. 1999] -... - 0 views

  •  
    NIH Article Abstract on a controlled study assessing feeding problems in infants with gastroesophageal reflux disease
Lee Vander Loop

Proton Pump Inhibitor Therapy and Bone Density in Premature Infants - 0 views

  •  
    Objective is to determine if a connection exists between proton pump inhibitor antacids and decreased rate of bone mineralization in neonates
1 - 13 of 13
Showing 20 items per page